Microenvironment Changes (in pH) Affect VEGF Alternative Splicing

被引:44
作者
Elias, Ana Paula [1 ]
Dias, Sergio [1 ,2 ,3 ]
机构
[1] CIPM, Inst Portugues Oncol Francisco Gentil, Angiogenesis Lab, Lisbon, Portugal
[2] Inst Med Mol, Lisbon, Portugal
[3] Inst Gulbenkian Ciencias, Oeiras, Portugal
关键词
Alternative splicing; Endometrial carcinoma; Microenvironment; SR proteins; VEGF;
D O I
10.1007/s12307-008-0013-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Vascular endothelial growth factor-A (VEGF-A) has several isoforms, which differ in their capacity to bind extracellular matrix proteins and also in their affinity for VEGF receptors. Although the relative contribution of the VEGF isoforms has been studied in tumor angiogenesis, little is known about the mechanisms that regulate the alternative splicing process. Here, we tested microenvironment cues that might regulate VEGF alternative splicing. To test this, we used endometrial cancer cells that produce all VEGF isoforms as a model, and exposed them to varying pH levels, hormones, glucose and CoCl2 (to mimic hypoxia). Low pH had the most consistent effects in inducing variations in VEGF splicing pattern (VEGF121 increased significantly, p< 0.001, when compared to VEGF145, 165 or 189). This was accompanied by activation of the p38 stress pathway and SR proteins (splicing factors) expression and phosphorylation. SF2/ASF, SRp20 and SRp40 down-regulation by siRNA impaired the effects of pH stimulation, blocking the shift in VEGF isoforms production. Taken together, we show for the first time that acidosis (low pH) regulates VEGF-A alternative splicing, may be through p38 activation and suggest the possible SR proteins involved in this process.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 28 条
[1]  
Bates DO, 2002, CANCER RES, V62, P4123
[2]   Tumorigenesis and the angiogenic switch [J].
Bergers, G ;
Benjamin, LE .
NATURE REVIEWS CANCER, 2003, 3 (06) :401-410
[3]   Increased expression of VEGF121/VEGF165-189 ratio results in a significant enhancement of human prostate tumor angiogenesis [J].
Catena, Raul ;
Muniz-Medina, Vanessa ;
Moralejo, Beatriz ;
Javierre, Biola ;
Best, Carolyn J. M. ;
Emmert-Buck, Michael R. ;
Greens, Jeffrey E. ;
Baker, Carl C. ;
Calvo, Alfonso .
INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (10) :2096-2109
[4]   Mitochondrial reactive oxygen species trigger hypoxia-induced transcription [J].
Chandel, NS ;
Maltepe, E ;
Goldwasser, E ;
Mathieu, CE ;
Simon, MC ;
Schumacker, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) :11715-11720
[5]  
Dent P, 2003, RADIAT RES, V159, P283, DOI 10.1667/0033-7587(2003)159[0283:SARIAO]2.0.CO
[6]  
2
[7]   Use of angiogenesis inhibitors in tumour treatment [J].
Fayette, M ;
Soria, JC ;
Armand, JP .
EUROPEAN JOURNAL OF CANCER, 2005, 41 (08) :1109-1116
[8]   Overexpression of VEGF121, but not VEGF165 or FGF-I, improves oxygenation in MCF-7 breast tumours [J].
Fenton, BM ;
Paoni, SF ;
Liu, W ;
Cheng, SY ;
Hu, B ;
Ding, I .
BRITISH JOURNAL OF CANCER, 2004, 90 (02) :430-435
[9]   THE ROLE OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IN PATHOLOGICAL ANGIOGENESIS [J].
FERRARA, N .
BREAST CANCER RESEARCH AND TREATMENT, 1995, 36 (02) :127-137
[10]  
Fukumura D, 2001, CANCER RES, V61, P6020